Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2003
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient
09/25/2003CA2478803A1 Methods of modulating cd200 receptors
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478760A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478348A1 Lotion compositions
09/25/2003CA2478074A1 Percutaneous absorption promoters and compositions for treating athlete's foot
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1345963A2 Isolation of purified tgf- 1 and tgf- 2 from bone tissue
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345919A2 Novel c-glycoside derivatives and use thereof
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
09/24/2003EP1345898A2 Teracyclic carbazole derivates and their use as spla2 inhibitors
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345620A2 Stable enzymatic wound debrider
09/24/2003EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
09/24/2003EP1345614A1 IMPROVED AND STABLE EXTRACT FROM i HYPERICUM PERFORATUM L. /i , METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A TOPICAL MEDICAMENT
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1345602A2 Treatments for neurogenetic disorders, impulse control disorders, and wound healing
09/24/2003EP1345601A2 Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis
09/24/2003EP1345600A1 New clinical treatment
09/24/2003EP1345585A1 Compositions for prevention and alleviation of skin wrinkles
09/24/2003EP1345568A2 Stable skin conditioning compositions containing retinoid boosters
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0845963B1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
09/24/2003CN1444647A Novel probiotics for pet. food applications
09/24/2003CN1444600A Use of ADNF polypeptides for enhancing learning and memory
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/24/2003CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444583A Method for preparing arylacetyl aminothiazole
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1444488A Use and improvement of honey in wound dressings
09/24/2003CN1444450A Allantoin-containing skin cream
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1443570A Application of thymosin alpha 1 in preparation of medicine for curing burn and scald
09/24/2003CN1443566A Eshu oil
09/24/2003CN1443564A Shizi oil
09/24/2003CN1443563A Huoluo oil
09/24/2003CN1443558A Preparation method of Bingling ointment for curing burn and scald
09/24/2003CN1443549A Medicine for preventing injury from producing scar
09/24/2003CN1443548A Medicine mixture with face-beautifying and health-care function and its preparation method
09/24/2003CN1443547A Ointment for curing acne and its preparation method
09/24/2003CN1443545A Medicine for curing acne and its preparation method
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/24/2003CN1121873C Burns and scalds treating medicine
09/24/2003CN1121870C Exterior applied medicine for treating leukoderma and its preparing process
09/24/2003CN1121863C Process for preparing medicinal attapulgite
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624202 Inhibitors of copper-containing amine oxidases
09/23/2003US6624199 Prophylaxis and treatment of acne and acne related skin diseases with aminobenzophenones, and novel compounds effective in the treatment, as well as pharmaceutical preparations containing these compounds and dosage units
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624177 Treating diseases in which matrix melatoproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624169 Urokinase inhibitors
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624157 Antitumor agents
09/23/2003US6624144 Matrix metalloproteinase inhibitors and down-regulators
09/23/2003US6623728 Cosmetic skin care compositions and containing gum mastic
09/18/2003WO2003076638A1 Angiogenesis inhibitors
09/18/2003WO2003076604A2 Surgical device for skin therapy or testing
09/18/2003WO2003076475A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076433A1 Pyrimidine compounds
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1065